MC2151A1 - Derives d'acides amines - Google Patents

Derives d'acides amines

Info

Publication number
MC2151A1
MC2151A1 MC902146A MC2146A MC2151A1 MC 2151 A1 MC2151 A1 MC 2151A1 MC 902146 A MC902146 A MC 902146A MC 2146 A MC2146 A MC 2146A MC 2151 A1 MC2151 A1 MC 2151A1
Authority
MC
Monaco
Prior art keywords
amino acid
acid derivatives
derivatives
amino
acid
Prior art date
Application number
MC902146A
Other languages
English (en)
French (fr)
Inventor
Branca Quirico
Neidhart Werner
Ramuz Henri
Stadler Heinz
Wostl Wolfgang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2151A1 publication Critical patent/MC2151A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/25Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC902146A 1989-09-04 1990-08-30 Derives d'acides amines MC2151A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH319289 1989-09-04
CH233690 1990-07-12

Publications (1)

Publication Number Publication Date
MC2151A1 true MC2151A1 (fr) 1992-03-10

Family

ID=25690187

Family Applications (1)

Application Number Title Priority Date Filing Date
MC902146A MC2151A1 (fr) 1989-09-04 1990-08-30 Derives d'acides amines

Country Status (14)

Country Link
US (1) US5688946A (xx)
EP (1) EP0416373A3 (xx)
JP (1) JPH0399047A (xx)
KR (1) KR910006224A (xx)
AU (1) AU646640B2 (xx)
CA (1) CA2023099A1 (xx)
FI (1) FI904360A0 (xx)
HU (1) HUT58060A (xx)
IE (1) IE903197A1 (xx)
IL (1) IL95503A0 (xx)
MC (1) MC2151A1 (xx)
NO (1) NO903832L (xx)
NZ (1) NZ235057A (xx)
PT (1) PT95192A (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275950A (en) * 1990-05-11 1994-01-04 Abbott Laboratories Process for the preparation of a renin inhibiting compound
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors
DE4040056A1 (de) * 1990-12-14 1992-06-17 Merck Patent Gmbh Saeureamide
TW198712B (xx) * 1991-04-17 1993-01-21 Hoffmann La Roche
US5268361A (en) * 1991-06-07 1993-12-07 Sri International Hydroxyazido derivatives and related compounds as renin inhibitors
CA2095671A1 (en) * 1992-06-04 1993-12-05 Quirico Branca Amino acid derivatives
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5268391A (en) * 1992-07-20 1993-12-07 C. D. Searle & Co. Propargyl-terminated cycloalkylalkyl-P2-site substituted aryl/alkylsulfonyl-terminated alanine amino-diol compounds for treatment of hypertension
US5314920A (en) * 1992-07-20 1994-05-24 G. D. Searle & Co. Ethynyl-alanine aryl/alkylsulfonyl-terminated amino-diol compounds for treatment of hypertension
US5317039A (en) * 1992-07-20 1994-05-31 G. D. Searle & Co. Cyclopropyl-alanine aryl/alkylsulfide/sulfonyl-terminated amino-diol compounds for treatment of hypertension
US5246969A (en) * 1992-07-20 1993-09-21 G. D. Searle & Co. Di-propargyl-containing aryl/alkylsulfonyl-terminated alanine amino-diol compounds for treatment of hypertension
US5212185A (en) * 1992-08-14 1993-05-18 G. D. Searle & Co. Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
US5312838A (en) * 1992-09-21 1994-05-17 G. D. Searle & Co. β-alanineamide aryl/alkylsulfide/sulfonyl-terminated amino-diol compounds for treatment of hypertension
ES2100109B1 (es) * 1993-07-14 1998-02-16 Squibb & Sons Inc Inhibidores de proteasas de aminodiol.
US5414018A (en) * 1993-09-24 1995-05-09 G. D. Searle & Co. Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension
US5416119A (en) * 1993-10-25 1995-05-16 G. D. Searle & Co. Alkylaminoalkyl-terminated sulfide/sulfonyl-containing cycloalkyl-alanine amino-diol compounds for treatment of hypertension
US5432201A (en) * 1993-11-22 1995-07-11 G. D. Searle & Co. Alkylaminoalkyl-sulfonyl-terminated β-alanineamide amino-diol compounds for treatment of hypertension
US6458775B1 (en) * 1998-07-06 2002-10-01 Guilford Pharmaceutical Inc. NAALADase inhibitors useful as pharmaceutical compounds and compositions
EP1159273A1 (en) * 1999-03-02 2001-12-05 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cathepsin s
JP2002201168A (ja) * 2000-12-28 2002-07-16 Kaken Pharmaceut Co Ltd シクロヘキサン誘導体
AU2002251913A1 (en) * 2001-02-02 2002-08-19 Millennium Pharmaceuticals, Inc. Hybrid antibodies and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
EP3052474A1 (en) * 2013-10-04 2016-08-10 Solvay Specialty Polymers Italy S.p.A. Process for the synthesis of fluoralkyl sulfonate salts
JP2019530678A (ja) * 2016-09-18 2019-10-24 エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド Yap1のoct4との相互作用を標的とするyap1阻害剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652551A (en) * 1984-06-22 1987-03-24 Abbott Laboratories Renin inhibiting compounds
US4845079A (en) * 1985-01-23 1989-07-04 Luly Jay R Peptidylaminodiols
JPS63503380A (ja) * 1986-01-16 1988-12-08 アボット・ラボラトリーズ ペプチド類似体
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
US4726941A (en) * 1986-01-23 1988-02-23 Regents Of The University Of Minnesota Acylated cyanamide composition for treating ethanol ingestion
US5032577A (en) * 1986-12-31 1991-07-16 Abbott Laboratories Peptidylaminodiols
ATE165085T1 (de) * 1987-09-29 1998-05-15 Banyu Pharma Co Ltd N-acylaminosäurederivate und deren verwendung
EP0313847A3 (en) * 1987-10-01 1989-11-29 G.D. Searle & Co. Non-peptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents
CA1328333C (en) * 1988-03-04 1994-04-05 Quirico Branca Amino acid derivatives
TW225540B (xx) * 1990-06-28 1994-06-21 Shionogi & Co
ZA917693B (en) * 1990-09-27 1992-05-27 Merck & Co Inc Fibrinogen receptor antagonists

Also Published As

Publication number Publication date
FI904360A0 (fi) 1990-09-04
JPH0399047A (ja) 1991-04-24
NO903832L (no) 1991-03-05
IE903197A1 (en) 1991-03-13
EP0416373A3 (en) 1992-05-27
US5688946A (en) 1997-11-18
NO903832D0 (no) 1990-09-03
HUT58060A (en) 1992-01-28
AU6136090A (en) 1991-03-07
EP0416373A2 (de) 1991-03-13
HU905676D0 (en) 1991-03-28
KR910006224A (ko) 1991-04-27
IL95503A0 (en) 1991-06-30
NZ235057A (en) 1994-12-22
PT95192A (pt) 1991-05-22
CA2023099A1 (en) 1991-03-05
AU646640B2 (en) 1994-03-03

Similar Documents

Publication Publication Date Title
MC2040A1 (fr) Derives d'acides amines
MC2022A1 (fr) Derives d'acides amines
MC2151A1 (fr) Derives d'acides amines
MC2106A1 (fr) Derives d'aminoacides
MC2103A1 (fr) Derives d'aminoacides
MA26449A1 (fr) Derives d'acides amines .
DE59008394D1 (de) Aminosäureamid-Derivate.
NO920417D0 (no) Aminosyrederivater
DK340088A (da) Aminosyrederivater
DE69025723T2 (de) N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutaminsäurederivate
FR2609998B1 (fr) Nouvelles substances antioxydantes derivees d'acides amines
MC1985A1 (fr) Derives d'acides amines
MC2107A1 (fr) Derives d'acides amines
DK0425925T3 (da) Substituerede aminosyreamid-derivater samt deres fremstilling og anvendelse
MC2264A1 (fr) Derives d'aminoacides
IT9021958A0 (it) Procedimento di purificazione dell'ammoniaca
PT75949B (fr) Procede pour la preparation de derives d'acides amines en n-(vinblastinoil-23)
MC2109A1 (fr) Dérivés d'acides aminés
DE69018816D1 (de) Aminosäurederivate.
FR2508036B1 (fr) Nouveaux derives d'acides amines na-3-cyano-propanoiques et application de ces derives
BG97094A (bg) Аминокиселинни производни
KR900007857A (ko) 1,4,2-옥사자포스폴리딘-4-아세트산, 2-알콕시-2-옥사이드의 아민염
DE59002430D1 (de) Cyclopropanoylaminosäureamid-Derivate.
FR2596762B1 (fr) Derives d'acides nucleiques
DK564988D0 (da) Aminosyrederivater

Legal Events

Date Code Title Description
YP Annual fee paid